(Q46969956)

27 December 2017

title

Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood (English)

1 reference

27 December 2017

polyostotic fibrous dysplasia

main subject

1 reference

Brendan Chan

1

1 reference

27 December 2017

Margaret Zacharin

series ordinal

2

1 reference

27 December 2017

publication date

1 January 2006

1 reference

27 December 2017

Journal of Pediatric Endocrinology and Metabolism

published in

1 reference

27 December 2017

volume

19

1 reference

27 December 2017

issue

1

1 reference

27 December 2017

page(s)

75-80

1 reference

27 December 2017

Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

New approaches for interpreting projected bone densitometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Paediatric management of endocrine complications in McCune-Albright syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2006.19.1.75

10.1515/JPEM.2006.19.1.75

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

release_2qaqm2j7jrcevpvtnrjvjzewve

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2qaqm2j7jrcevpvtnrjvjzewve

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

27 December 2017